JSLA
ActiveSummary
JSLA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12,657 and a net result of €48,810. Equity fluctuates too strongly from year to year to read a trend from it. The computed 12-month bankruptcy probability is 1.3% (low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 04-11-2022 Normal situation
- Activity
- “La société a pour objet I'exercice en son nom et pour son compte de…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.337.776.016 1440 Braine-le-Château, since 04-11-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 28-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.3%
- Gross margin
- €66,561
- ▼ 15.5%
- Turnover
- ≈ €200,000
- estimated
- Profit
- €48,810
- ▼ 18.5%
- Equity
- €12,657
- ▼ 62.6%
- Total assets
- €58,362
- ▲ 13.3%
- Staff
- ≈ 0.1 FTE
- estimated
Score breakdownraises riskFounded in 2022No main activity registeredlowers riskLiquidity: current ratio 1.24, cash €30,046Size: total assets €58,362Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 29% of them on solvency, 54% on liquidity, 90% on profitability and 8% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 4 accounts on average 34 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 23-05-2026 PDF all 4 filings
Every figure per financial year
The operating result for 2025 is 16% lower than in 2024.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Investments
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Tangible fixed assets | - | - | €1,578 | - |
| Financial fixed assets | - | - | €750 | - |
| Depreciation and write-downs of the year | €1,150 | - | €53 | €526 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €138 | €1,520 | €1,520 | €1,560 | ▲ 2.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,150 | - | €53 | €526 | ▲ 889% |
| Other operating charges640/8 | - | €271 | €511 | €329 | ▼ 35.6% |
| Gross operating margin9900 | €2,399 | €59,576 | €78,784 | €66,561 | ▼ 15.5% |
| Operating profit (loss)9901 | €1,111 | €57,785 | €76,700 | €64,146 | ▼ 16.4% |
| Financial income75/76B | - | €95 | €239 | €282 | ▲ 17.7% |
| Recurring financial income75 | - | €95 | €239 | €282 | ▲ 17.7% |
| Financial charges65/66B | €5 | €52 | €39 | €98 | ▲ 150% |
| Recurring financial charges65 | €5 | €52 | €39 | €98 | ▲ 150% |
| Profit (loss) for the period before taxes9903 | €1,106 | €57,827 | €76,901 | €64,330 | ▼ 16.3% |
| Income taxes67/77 | €405 | €12,542 | €17,039 | €15,520 | ▼ 8.9% |
| Profit (loss) for the period9904 | €701 | €45,286 | €59,861 | €48,810 | ▼ 18.5% |
| Profit (loss) for the period to be appropriated9905 | €701 | €45,286 | €59,861 | €48,810 | ▼ 18.5% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €5,397 | €62,597 | €51,503 | €58,362 | ▲ 13.3% |
| Fixed assets21/28 | - | - | €2,275 | €1,749 | ▼ 23.1% |
| Tangible fixed assets22/27 | - | - | €1,525 | €999 | ▼ 34.5% |
| Furniture and vehicles24 | - | - | €1,525 | €999 | ▼ 34.5% |
| Financial fixed assets28 | - | - | €750 | €750 | = |
| Current assets29/58 | €5,397 | €62,597 | €49,228 | €56,614 | ▲ 15.0% |
| Amounts receivable within one year40/41 | - | €12,606 | €14,093 | €26,568 | ▲ 88.5% |
| Trade receivables40 | - | €12,606 | €14,093 | €16,568 | ▲ 17.6% |
| Other amounts receivable41 | - | - | - | €10,000 | - |
| Cash at bank and in hand54/58 | €5,397 | €49,490 | €32,957 | €30,046 | ▼ 8.8% |
| Deferred charges and accrued income490/1 | - | €501 | €2,178 | - | - |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €5,397 | €62,597 | €51,503 | €58,362 | ▲ 13.3% |
| Equity10/15 | €3,701 | €10,986 | €33,848 | €12,657 | ▼ 62.6% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | €3,000 | = |
| Reserves13 | - | €7,986 | €7,986 | €7,986 | = |
| Distributable reserves133 | - | €7,986 | €7,986 | €7,986 | = |
| Profit (loss) carried forward14 | €701 | - | €22,861 | €1,671 | ▼ 92.7% |
| Amounts payable17/49 | €1,697 | €51,611 | €17,655 | €45,705 | ▲ 159% |
| Amounts payable within one year42/48 | €1,697 | €51,611 | €17,655 | €45,705 | ▲ 159% |
| Trade debts44 | €1,292 | €189 | €601 | €170 | ▼ 71.7% |
| Suppliers440/4 | €1,292 | €189 | €601 | €170 | ▼ 71.7% |
| Taxes, remuneration and social security45 | €405 | €23,942 | €17,039 | €20,020 | ▲ 17.5% |
| Taxes450/3 | €405 | €23,942 | €17,039 | €20,020 | ▲ 17.5% |
| Other amounts payable47/48 | - | €27,480 | €14 | €25,514 | ▲ 1,772× |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €701 | €45,286 | €59,861 | €48,810 | ▼ 18.5% |
| + Depreciation and write-downs630 | €1,150 | - | €53 | €526 | ▲ 889% |
| Operating cash flow (approximation) | €1,851 | €45,286 | €59,914 | €49,336 | ▼ 17.7% |
| Investment in fixed assets (approximation) | - | - | - | €0 | - |
| Change in cash | - | €44,092 | -€16,533 | -€2,911 | ▲ 82.4% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 7,976 companies had the same profile as JSLA has now. Two years later, 94.3% were still going and 3.6% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
Another 0.3% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of JSLA itself: 1.3% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,976 companies, not a prediction for JSLA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Board & ownership
Directors
Owners and capital
Shareholders
- HALTOUT Jabir 100 shares (100%) · in cash
Capital transactions
- 08-11-2022 Incorporation · €3,000 · 100 shares
Articles of association
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Désigner liquidateur(s) déterminer pouvoirs et émoluments, problématiques portée médicale: gestion dossiers médicaux, secret médical, actes…”
Articles of association, deed of 08-11-2022 (in French)
Network & group
JSLA shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of JSLA. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
11-10
Gazette deed
Registered office moved from Bruxelles to Braine-le-ChâteauDirector in office3 points ▸
- General meeting, 12-09-2024
- Registered-office move, rue de la Vallée 11 à 1440 Braine-le-Château
- Director in office, Jabir Haltout (director)
08-11
Gazette deed
IncorporationStarting capital €3,000 · Appointment: HALTOUT Jabir (director) · Founder10 points ▸
- Founder, HALTOUT Jabir (comparant)
- Incorporation, “JSLA” (deed in French)
- Founding capital, €3,000
- Bank account, 3000, EUR
- Other provision, “fonds disponibles”, 3000 (deed in French)
- Capital
- Board rule, 1, “assemblée” (deed in French)
- Director appointment, HALTOUT Jabir (director (not named in the articles))
- Other provision, “début activités, acquisition personnalité juridique soit dépôt au greffe expédition acte constitutif conformément loi” (deed in French)
- Other provision, “droit d’écriture Code des droits et taxes divers, pro fisco” (deed in French)
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
1 former office
- Avenue des Citronniers 23, 1020 Bruxelles until 12-09-2024 · act of 11-10-2024
Activities
3 activities
- La société a pour objet I'exercice en son nom et pour son compte de la médecine spécialisée ou générale.
- La société pourra, pour autant que cela ne porte pas atteinte à la vocation médicale de la société, ni ne conduise au développement d’une quelconque activité commerciale et de façon purement accessoire, accomplir des investissements mobiliers ou immobiliers, sans que cela n’ait nécessairement un rapport direct avec l’exercice de la médecine.
- Moyennant I'accord du Conseil compétent de I'Ordre des Médecins, elle peut s'intéresser par toutes voies de droit, dans toutes affaires, entreprises ou sociétés ayant un objet identique ou analogue, ou qui sont de nature à favoriser le fonctionnement de la société.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 25015E0227/00B000 | Wallonia | 1,845 m² | 1 · 156 m² | 6.9 m · 2 |
1 of these parcels carries protected heritage. Expect extra rules on renovation or sale.